Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05933434
PHASE1/PHASE2

Allogenic Mesenchymal Stem Cell Intraarticular Injection for Knee Osteoarthritis Therapy

Sponsor: Aarhus University Hospital

View on ClinicalTrials.gov

Summary

This phase I and II double blinded randomized clinical controlled trial investigates the safety and efficacy of intraarticular knee injection with allogenic adipose derived mesenchymal stem cells (AD-MSC), in patients suffering from mild-moderate knee osteoarthritis compared to placebo injection with saline.

Official title: Allogenic Mesenchymal Stem Cell Intraarticular Injection for Knee Osteoarthritis Therapy, an RCT Explorative Mode-of-action Study

Key Details

Gender

All

Age Range

40 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2024-03-07

Completion Date

2030-10

Last Updated

2024-06-11

Healthy Volunteers

No

Interventions

BIOLOGICAL

Allogenic adipose derived mesenchymal stem cells (AD-MSC)

Laboratory isolated, cultivated and cryopreserved allogenic adipose derived mesenchymal stem cells (AD-MSC) from health donors undergoing cometic plastic surgery will be thawed on the injection day and formulated in 10 mL saline. The AD-MSCs will then be intraarticular injected using ultrasonic guidance.

OTHER

Saline

10 mL saline will be intraarticular injected using ultrasonic guidance.

Locations (1)

Aarhus University

Aarhus N, Denmark